<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupKathryn Alsop, Gillian Mitchell, Sián Fereday et al.|Journal of Clinical Oncology|2012Cited by 1.2k
Comprehensive molecular characterization of mitochondrial genomes in human cancersYuan Yuan, Axel Aretz, Young Seok Ju et al.|Nature Genetics|2020Cited by 516
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J. Ramus, Simon A. Gayther, Ed Dicks et al.|JNCI Journal of the National Cancer Institute|2015Cited by 441
Synthetic lethality between <i>CCNE1</i> amplification and loss of <i>BRCA1</i>Dariush Etemadmoghadam, David D.L. Bowtell, Barbara A. Weir et al.|Proceedings of the National Academy of Sciences|2013Cited by 227
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment OutcomeZhigang C. Wang, Nicolai J. Birkbak, Aedín C. Culhane et al.|Clinical Cancer Research|2012Cited by 162